Compass Therapeutics, Inc.
NASDAQCompass Therapeutics dropped sharply this week while short sellers trimmed positions slightly. Cost to borrow fell to a 30-day low. Options flow turned more cautious. Insider CEO sales continue a multi-quarter pattern. CMPX closed at $5.03 on April 24, down 3.45% on the day. The stock fell 16.2% over the week and lost 5.6% over the past month. The…
Snapshot as of 11 May 2026
Compass Therapeutics dropped sharply this week while short sellers trimmed positions slightly. Cost to borrow fell to a 30-day low. Options flow turned more cautious. Insider CEO sales continue a multi-quarter…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CMPX — free to start on ORTEX.
Sign up for free →Open CMPX on ORTEX